In 1956, Hayashi and Nagai showed that y-amino-f3-hydroxbutyric acid (GABOB), when introduced into cerebrospinal fluid, inhibited seizures which were produced by electrical stimulation of the motor cortex in dogs. We tried to apply GABOB to the epileptic patients by means of lumbar puncture and obtained the following results; complete inhibition of seizure 13 (59%), improved 6 (27%), and unchanged 3 (14%) among 22 patients.
A Study of the Serum Proteins of Cerebrospinal
Fluid in Epilepsia Since 1955 we have performed cerebral hemispherectomy in ten cases of in fantile hemiplegia and followed up eight survived cases with an average of fiv years. Two cases died after the operation.
According to the pathological picture found in the removed hemisphere w have been able to divide these ten cases into two groups: a) eight cases with diffuse changes and b) two cases exhibiting localized changes. In most cases of th group a) the microscopic changes were not remarkable which made us suspect so called "sub-anatomic" changes. As to the group a) five cases had the favourably results, one case improved slightly and two cases were in vain postoperatively Group b) which consists of one case of porencephaly and another case of sclerosi around the Sylvian fissure due to postdiphtheric infarction had the marked im provement postoperatively. After the operation motor and sensory impairment was encountered in non of the cases, but spasticity has tended to increase as time passes , so that the im portance of rehabilitation after the operation should be emphasized. Epilepti, seizures were well controlled and their personality also became socially adaptable following the operation.
In most cases temporary autonomic dysfunction was en countered and one patient died after many episodes of autonomic nervous dys function postoperatively.
In six cases pubertas precox and obesity were seen Dilatation of the lateral ventricle of the residual brain was seen in all five case which were examined.
The marked change of the residual brain at autopsy in a patient who die,
